Armenia Pharmaceuticals & Healthcare Q4 2018
We remain confident of our current forecasts for Armenia's pharmaceutical market, which continues to offerfew opportunities for multinational drugmakers. The new authorities seem to broadly follow the previous administration's courseand, as such, publicly funded access to healthcare services will remain lacking. Longer-term prospects remain dependent on thewider economic situation, especially as private out-of-pocket spending remains the dominant source of healthcare funding.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook